Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion type Assertion NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_head.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion description "[These results point to IL-6 as an important mediator of bone loss in DMD and suggest that targeted anti-IL-6 therapy may have a positive impact on the bone phenotype in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_provenance.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion evidence source_evidence_literature NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_provenance.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion SIO_000772 21509823 NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_provenance.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion wasDerivedFrom befree-20150227 NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_provenance.
- NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_assertion wasGeneratedBy ECO_0000203 NP497741.RAwEe_uJ2TtXpzoF1tbSf55sGs9dtF9sTxwk326oSJwCs130_provenance.